SEC Filing Update: #JBIO Jade Biosciences, Inc. : $25.00

Sector: Healthcare | YTD: 🔼+ 76.30% The SEC disclosed Today (14-AUG-2026) that VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. has INCREASED #JBIO Shares by 0.58% 🟢 * Previous Holdings: 5.12M Shares * Current Holdings: 5.15M Shares * Increase+29.47K * Increased(%)+0.58% * Ownership: 8.3% * Estimated Investment Value: $654.78K https://www.thinksabio.com/reports/isr/JBIO Institutional ownership in #JBIO has been steadily rising over the past 8 quarters in Shares: Q2 2024: 776.63K Q3 2024: 789.84K Q4 2024: 861.85K Q1 2025: 1.31M Q2 2025: 31.56M Q3 2025: 31.62M Q4 2025: 47.08M Q1 2026: 49.85M The quarterly average prices of #JBIO: Q4 2025: $11.65 Q1 2026: $14.48 📌 Institutional activity in the last 30 days for #JBIO: • Paradigm Biocapital Advisors LP – Increased holdings by 2,963,558 shares (17-JUL-2026)